Giant Cell Temporal Arteritis Followed by Severe Encephalopathy Induced by Immunotherapy in a Patient with Metastatic Renal Cell Carcinoma Achieving Durable Partial Response: A Case Report
Both GCA and the subsequent encephalopathy in our patient responded well to the corticosteroid therapy, leading to the complete resolution of the symptoms and the patient achieved a durable partial response. Although the risk of severe neurologic irAEs affecting the central nervous system induced by IO re-administration, following previous discontinuation due to irAE, is not well-defined because of their rarity, this case highlights the need for caution, particularly in cases with a history of previous irAE-associated GCA.
Authors
- Ondřej Fiala (ORCID: https://orcid.org/0000-0002-4096-7385)
- Milan Hora (ORCID: https://orcid.org/0000-0002-5061-3687)
- Kristýna Pivovarčíková (ORCID: https://orcid.org/0000-0002-9553-0105)
- Jindřich Fínek (ORCID: https://orcid.org/0000-0002-7750-9345)
- Jan Baxa (ORCID: https://orcid.org/0000-0002-4896-1658)
- Petr Stránský
- Michaela Tkadlecová
- Dominika Šiková
Institutions
- Charles University (CZ)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1159/000540660
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Univerzita Karlova v Praze
- European Commission
- Fakultní Nemocnice Plzen